Fibromyalgia Treatment with Pregabalin

Fibromyalgia

Fibromyalgia is one of the common causes of widespread pain and fatigue associated with other symptoms. Apart from the pain and fatigue there are symptoms of sleep disturbance, impaired physical functioning, altered mood and diminished or poorer health-related quality of life.

The exact cause of this condition is unknown but there are several studies that connect abnormal pain perceptions with fibromyalgia. The pain modulation pathways in the brain seem to be altered to make pain sensitivity heightened among these patients and in addition there are lowered pain thresholds.

Pregabalin

Pregabalin is a medication that prevents the release of pronociceptive neurotransmitters or the chemical messengers of brain from the pre-synaptic membrane in the brain.

Pregabalin is a calcium channel alpha(2)delta-subunit ligand that has several properties including pain relief, relief from anxiety and reductions of symptoms in epilepsy patients.

Due to its ability to modulate the neurotransmitter release from the brain synapses, there may be benefits of this drug in fibromyalgia patients.

Pregabalin and fibromyalgia

Studies however have shown that at the approved dosages, oral pregabalin provides only a moderate benefit to the patients of fibromyalgia compared to dummy medications or placebo.

However, more than 30% pain relief has been seen with pregabalin in patients who responded favourably to the medication. Responders also showed pain relief lasting for at least 6 months on use. Longer studies are needed as most patients with fibromyalgia suffer for life.

Pregabalin treatment reduces the pain and also improves quality of life and overall health status among fibromyalgia patients by reducing pain, anxiety, fatigue and sleep quality.

The commonest side effects of use of this medication include dizziness, weight gain and increased sleepiness. These however are well tolerated by most patients. Pregabalin is thus considered an important medication that could be used widely among patients with fibromyalgia.

Pregabalin was the first FDA drug approved drug for the management of fibromyalgia. It could be taken at bed time and combined with either duloxetine or milnacipran on awakening in more effective management of symptoms of fibromyalgia.

Further Reading

Last Updated: Feb 26, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, February 26). Fibromyalgia Treatment with Pregabalin. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/health/Fibromyalgia-Treatment-with-Pregabalin.aspx.

  • MLA

    Mandal, Ananya. "Fibromyalgia Treatment with Pregabalin". News-Medical. 21 December 2024. <https://www.news-medical.net/health/Fibromyalgia-Treatment-with-Pregabalin.aspx>.

  • Chicago

    Mandal, Ananya. "Fibromyalgia Treatment with Pregabalin". News-Medical. https://www.news-medical.net/health/Fibromyalgia-Treatment-with-Pregabalin.aspx. (accessed December 21, 2024).

  • Harvard

    Mandal, Ananya. 2019. Fibromyalgia Treatment with Pregabalin. News-Medical, viewed 21 December 2024, https://www.news-medical.net/health/Fibromyalgia-Treatment-with-Pregabalin.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Association between vitamin D supplementation and fatigue